GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes
Status:
Completed
Trial end date:
2022-01-03
Target enrollment:
Participant gender:
Summary
The study is conducted at Arash Women's Hospital on all women undergoing the frozen embryo
transfer cycle. Patients who signed informed consent will be randomly divided into two
groups. The first group will receive GnRH agonist plus hormone replacement therapy for
endometrial preparation. Group 2 will receive hormone replacement therapy. The random
allocation and final outcome of the study will be assessed by a person who is unaware of the
study process. Also, the statistician will be unaware of the study process